Mohan, Mahendra K. http://orcid.org/0000-0002-6827-592X
Thorat, Ketan http://orcid.org/0000-0001-8501-4855
Puthiyapurayil, Theja Parassini http://orcid.org/0009-0002-1620-6049
Sunnapu, Omprakash http://orcid.org/0000-0003-1940-7188
Chandrashekharappa, Sandeep http://orcid.org/0000-0003-2475-7270
Ravula, Venkatesh http://orcid.org/0000-0002-0229-7640
Khader, Rajamohammed http://orcid.org/0009-0002-6902-381X
Sankaranarayanan, Aravind http://orcid.org/0000-0002-5832-6770
Muhammad, Hadi http://orcid.org/0009-0008-7774-8240
Vemula, Praveen Kumar http://orcid.org/0000-0003-0279-4230
Article History
Received: 18 October 2023
Accepted: 23 May 2024
First Online: 6 June 2024
Competing interests
: P.K.V., K.T., and S.C. hold patents related to this technology: “Composition, materials, and methods for deactivating toxic agents” (Granted Indian patent: 201841006678 and granted Sri Lankan Patent # 20419). All compositions and methods of use described in this manuscript were covered in the patent applications. P.K.V., K.T., and S.C. are inventors of patents that were licensed to Sepio Health, a company that has licensed IP generated by P.K.V., K.T., and S.C., that may benefit financially if the IP is further validated. The interests of P.K.V. were reviewed and are subject to a management plan overseen by his institution in accordance with its conflict of interest policies. P.K.V. and O.S. are equity holders in Sepio Health. The remaining authors declare no competing interests.